EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiomics and Systematic Analyses Reveal the Roles of Hemoglobin and the HIF‐1 Pathway in Polycystic Ovary Syndrome

Guiquan Wang iD, Weian Mao, Yurong Zhang iD, Haiyan Yang, Ming Zhu, Yan Li, Wei Chen, Yi Chen, Chen Lou, Ping Li, Hsun-Ming Chang, Shuai Yuan und 2 weitere

Advanced Science · 2025-04 · 12 (14)

DOI: 10.1002/advs.202411679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.02.2025. Verfasst von Guiquan Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Hemoglobins, Hypoxia-Inducible Factor 1. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Key Clinical Projects of Peking University Third Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) affects reproductive and cardiometabolic health, yet its pathogenesis remains unclear. Emerging evidence links hemoglobin levels to metabolic disorders, suggesting a potential role in PCOS development. Here, we integrated a large‐scale cohort study, Mendelian randomization (A genetic tool to infer causal relationships), bioinformatics analyses, and in vitro experiments to investigate the relationship between hemoglobin levels and PCOS. In a cohort of 20 602 women, each 10 g L −1 elevation in hemoglobin levels is associated with 22% higher odds of PCOS (adjusted odds ratio: 1.22, 95% confidence interval: 1.15–1.29, P < 0.001) and PCOS manifestations, particularly hyperandrogenism. Mendelian randomization analysis confirms that higher hemoglobin levels are associated with increased PCOS risk and elevated testosterone levels. The hypoxia‐inducible factor 1 (HIF‐1) pathway is enriched, identifying three testosterone‐associated genes (nuclear factor kappa B (NFKB1) , insulin receptor (INSR) , protein kinase C alpha. Colocalization and druggability analysis supports shared genetic regions and confirmed these genes as druggable targets. Upregulation of NFKB1 and INSR are confirmed in both blood and ovarian granulosa cells of PCOS patients. The findings demonstrate that higher‐end normal hemoglobin levels are associated with increased PCOS risk, potentially through a mechanism of elevating testosterone levels involving the HIF‐1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeHemoglobinsHypoxia-Inducible Factor 1HumansFemaleAdultCohort StudiesMendelian Randomization AnalysisSignal TransductionTestosteroneMultiomicsHypoxia-Inducible Factor 1, alpha Subunit

Stichwörter der Autor:innen

causalityhemoglobinhyperandrogenismhypoxia‐inducible factorpolycystic ovary syndrome

Substanzen

HemoglobinsHypoxia-Inducible Factor 1TestosteroneHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Department of Reproductive Medicine, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
  • Xiamen Key Laboratory of Reproduction and Genetics, Xiamen, 361023, China.
  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
  • State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, National Clinical Research Center for Obstetrics and Gynec…
  • Reproductive Medicine Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • The First School of Medicine, Wenzhou Medical University, Wenzhou, 325035, China.

ORCID-Profile: Guiquan Wang, Yurong Zhang, Yue Zhao, Liangshan Mu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Key Clinical Projects of Peking University Third Hospital
  • Pilot Project-China Reproductive Health Public Welfare Foundation

Zitieren

APA

Wang, G., Mao, W., Zhang, Y., Yang, H., Zhu, M., Li, Y., Chen, W., Chen, Y., Lou, C., Li, P., Chang, H. M., Yuan, S., Zhao, Y., & Mu, L. (2025). Multiomics and Systematic Analyses Reveal the Roles of Hemoglobin and the HIF‐1 Pathway in Polycystic Ovary Syndrome. Advanced Science, 12(14). https://doi.org/10.1002/advs.202411679

Vancouver

Wang G, Mao W, Zhang Y, Yang H, Zhu M, Li Y, et al. Multiomics and Systematic Analyses Reveal the Roles of Hemoglobin and the HIF‐1 Pathway in Polycystic Ovary Syndrome. Advanced Science. 2025;12(14). doi:10.1002/advs.202411679

BibTeX
@article{Wang2025,
  author = {Wang, Guiquan and Mao, Weian and Zhang, Yurong and Yang, Haiyan and Zhu, Ming and Li, Yan and Chen, Wei and Chen, Yi and Lou, Chen and Li, Ping and Chang, Hsun-Ming and Yuan, Shuai and Zhao, Yue and Mu, Liangshan},
  title = {Multiomics and Systematic Analyses Reveal the Roles of Hemoglobin and the HIF‐1 Pathway in Polycystic Ovary Syndrome},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {14},
  doi = {10.1002/advs.202411679}
}
Kostenlos starten →